citalopram has been researched along with DDPAC in 5 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purposes of this study were first, to evaluate the effectiveness of citalopram in treating behavioral disturbances in frontotemporal dementia (FTD) subjects and second, to determine whether an association exists between serotonergic function, as determined by a neuroendocrine challenge, and treatment response." | 5.16 | Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. ( Black, SE; Cappell, J; Chow, T; Herrmann, N; Lanctôt, KL; Tang-Wai, DF, 2012) |
| "Sequential therapeutic trials for catatonoid frontal signs in clinically-evident frontotemporal dementia (n = 2) revealed differential benefits for lorazepam, amantadine, memantine, pramipexole, aripiprazole, quetiapine, citalopram, and donepezil, although certain signs also worsened." | 3.76 | Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. ( Greenway, LL; Kuppuswamy, PS; Lauterbach, EC, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikenouchi, A | 1 |
| Seki, I | 1 |
| Takaoka, K | 1 |
| Okamoto, N | 1 |
| Murakami, S | 1 |
| Yoshimura, R | 1 |
| Borisovskaya, A | 1 |
| Augsburger, J | 1 |
| Pascualy, M | 1 |
| Hughes, LE | 1 |
| Rittman, T | 1 |
| Regenthal, R | 1 |
| Robbins, TW | 1 |
| Rowe, JB | 1 |
| Lauterbach, EC | 1 |
| Kuppuswamy, PS | 1 |
| Greenway, LL | 1 |
| Herrmann, N | 1 |
| Black, SE | 1 |
| Chow, T | 1 |
| Cappell, J | 1 |
| Tang-Wai, DF | 1 |
| Lanctôt, KL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia[NCT00376051] | Phase 4 | 22 participants (Anticipated) | Interventional | 2006-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for citalopram and DDPAC
| Article | Year |
|---|---|
Improving response inhibition systems in frontotemporal dementia with citalopram.
Topics: Aged; Citalopram; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Frontotem | 2015 |
Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia.
Topics: Aged; Behavioral Symptoms; Biomarkers; Citalopram; Female; Frontotemporal Dementia; Humans; Male; Pi | 2012 |
3 other studies available for citalopram and DDPAC
| Article | Year |
|---|---|
A male case of frontotemporal lobar degeneration with behavioural and psychiatric symptoms responding to a low dose of escitalopram.
Topics: Citalopram; Frontotemporal Dementia; Frontotemporal Lobar Degeneration; Humans; Male | 2021 |
Electroconvulsive therapy for frontotemporal dementia with comorbid major depressive disorder.
Topics: Aged; Antidepressive Agents; Citalopram; Combined Modality Therapy; Depressive Disorder, Major; Elec | 2014 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinica | 2010 |